Analysis and Purification
of Bioactive Natural Products:
The AnaPurNa Study by Pauli, Guido F. et al.
Analysis and Puriﬁcation of Bioactive Natural Products: The
AnaPurNa Study
Guido F. Pauli,*
,†,‡ Shao-Nong Chen,
† J. Brent Friesen,
†,§ James B. McAlpine,
†,‡ and Birgit U. Jaki
†,‡
†Department of Medicinal Chemistry and Pharmacognosy and
‡Institute for Tuberculosis Research, College of Pharmacy, University
of Illinois at Chicago, Chicago, Illinois 60612, United States
§Physical Sciences Department, Rosary College of Arts and Sciences, Dominican University, River Forest, Illinois 60305, United
States
* S Supporting Information
ABSTRACT: Based on a meta-analysis of data mined from almost
2000 publications on bioactive natural products (NPs) from >80 000
pages of 13 diﬀerent journals published in 1998−1999, 2004−2005,
and 2009−2010, the aim of this systematic review is to provide both a
survey of the status quo and a perspective for analytical methodology
used for isolation and purity assessment of bioactive NPs. The study provides numerical measures of the common means of
sourcing NPs, the chromatographic methodology employed for NP puriﬁcation, and the role of spectroscopy and purity
assessment in NP characterization. A link is proposed between the observed use of various analytical methodologies, the
challenges posed by the complexity of metabolomes, and the inescapable residual complexity of puriﬁed NPs and their biological
assessment. The data provide inspiration for the development of innovative methods for NP analysis as a means of advancing the
role of naturally occurring compounds as a viable source of biologically active agents with relevance for human health and global
beneﬁt.
■ INTRODUCTION
Preface. Natural product (NP) research is a demanding
science, requiring an in-depth knowledge of many aspects of
organic, analytical, and biological chemistry, including separa-
tion science, spectroscopy, biosynthesis, and pharmacology, as
well as the biology and taxonomy of the investigated phyla.
Nonetheless, most contemporary practitioners would agree that
the role of this discipline within biomedical science has
declined, as evidenced by its present abandonment by most
large pharmaceutical companies in their search for new
chemical entities to provide new drug discovery leads. This
review takes a comprehensive look at the current practice of NP
research, with the aim of pinpointing potential areas where the
practitioners might improve the overall eﬃciency of this type of
work. By focusing on NP chemistry as one fundamental aspect
of NP research, it might be possible to recognize patterns that
impact the bigger picture and identify opportunities that
otherwise would go unnoticed. This review intends to stimulate
discussion and inspire the development of new approaches to
yield more rapid results and a greater number of new chemical
entities discovered, and thereby promote the future role of NP
research in interdisciplinary programs.
Role and Sourcing of Natural Products. A series of
excellent articles, coauthored by G. M. Cragg, D. J. Newman,
and colleagues,
1−5 has documented the invaluable role of NPs
in drug discovery. Underlying evidence came from an extensive
meta-analysis of the primary literature of all drugs, in or
completing FDA-approved studies within a set time frame and
classifying them according to their origin as NPs, inspired by
NPs, analogues of these two classes, or from non-NP sources.
These analyses have indicated that a high proportion of new
drugs approved in Western countries in recent decades are, in
some manner, connected to NPs. As primordial biosynthetic
pathways endow Nature’s library of chemicals with an
evolutionary advantage over man-made chemicals, NP libraries
are keyed to Nature’s biochemistry and diversity and, thus,
continue to be an attractive source
6 for new bioactive agents,
for both therapeutic and diagnostic uses. Moreover, the
chemical diversity in NPs is tied intrinsically to the complexity
of the metabolome contained in the source material.
Ultimately, both the discovery and the resupply of bioactive
NPs depend on the availability of preparative-scale analytical
methods having the capability of resolving the complex primary
and secondary metabolomic mixtures that are typically isolated
from the source organism, yielding a puriﬁed NP (NP in Figure
1), and eventually providing a well-characterized NP as a single
chemical entity (SCE; Figure 1). It should be noted that, in the
practice of NP chemistry research, a puriﬁed NP does not
necessarily represent an SCE, but may only have been puriﬁed
to the degree necessary, e.g., for structure elucidation or
identiﬁcation. A SCE may be deﬁned as a substance for which
all chemical, physical, and biological characteristics can be
attributed to a single molecular structure. Accordingly, a NP
becomes a SCE only after its singleton character has been
demonstrated (high-purity NP). This is in line with practice for
SCEs that are used and regulated as drugs: their purity plays a
pivotal role in all pharmacopoeias worldwide. This topic has
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mononitrate preparation containing pyrimethamine as an
impurity caused the death of more than 100 patients in
Pakistan.
7 This tragedy demonstrates the importance of purity
as a parameter for the safety of medicines, but also exempliﬁes
that purity should never be ignored and always be part of
quality control of drugs − and NPs.
The majority of pure NPs represent rare chemicals of
extremely limited supply. Frequently, particularly in the case of
newly reported structures, such compounds are also unique
commodities and are only immediately available from a single
source, namely, the original investigators, or by re-isolation.
Practitioners of NP chemistry can generally observe additional
factors that contribute to the exclusivity of NP samples: (i)
their consumption in the bioassay systems of contemporary NP
research programs; (ii) a general trend to smaller sample sizes,
leading to smaller yields; (iii) the frequently unfavorable
consistency of small-scale isolation products, and (iv) the
practical challenges of handling small samples for distribution,
such as precise weighing in the submilligram range.
Considering both commercial and noncommercial/academic
sources and supply chains, most pure NP compounds can be
traced back ultimately to crude natural materials (extracts) that
require various puriﬁcation steps before being considered
“pure”. Consequently, “pure” NPs carry a natural signature in
the form of a characteristic impurity proﬁle called residual
complexity (RC), which originates ultimately from the
biosynthetic cocktail(s) of the producing organism(s).
8 As a
result of the authors’ own experience, the often elaborate
puriﬁcation process potentially adds unwanted “tracer”
components to the puriﬁed NP, such as sorbents, laboratory
pollutants, residual solvents, or other chemicals, which can
evade detection by the analytical methods used. These
considerations also aﬀect studies with a biological or
pharmacological focus that utilize as tools NPs, which might
be acquired from outside sources. Most such studies generally
consider NPs as “ﬁne chemicals” rather than a material derived
from Nature. Exceptions may be compounds obtained by
(semi)synthesis, a process typically only accomplished at an
advanced discovery stage and for select NPs. Even in these
instances, as minor congeners potentially can undergo the same
reaction, carryover of minor components (commonly ana-
logues) through semisynthetic schemes has to be considered.
All of these considerations reveal NPs as being both highly
sought after and hard to obtain entities. They also explain why
the NP drug discovery process and the biological assessment of
NPs to date are almost inevitably tied to preparative-scale
analytical methods used for NP puriﬁcation. The ability to
purify a few milligrams of a rare NP from kilograms of a crude
extract has been one of the signiﬁcant skills of scientists trained
in NP chemistry, pharmacognosy, and analogous disciplines
and represents one of the keys to NP research.
Approach. In clinical research, numeric meta-analysis of
literature is a well-established tool, allowing recognition of
more general trends, and is used frequently to improve clinical
practice. While such meta-analyses are rarely done in NP
research, they can be very helpful tools for gaining new and
more generalized insights. One example of such a report is the
study by G. A. Cordell et al.,
9 revealing that only about 3% of
some 20 000 known alkaloids have been evaluated biologically
in more than ﬁve test systems, whereas 36% of alkaloids that
were evaluated in 20 or more bioassays are pharmaceutically
relevant. The present contribution is based on the meta-analysis
of the recent literature with a focus on parameters that reﬂect
the analysis and puriﬁcation of bioactive NPs (AnaPurNa).
The production of pure NPs of controlled quality (cNPs)
involves two main aspects: (a) the actual purification process
used for NP isolation, i.e., the (semi)preparative-scale analytical
method employed; (b) the assessment of the purity [or residual
complexity (RC)] of the isolated NP, including the analytical
method used for purity assessment. The aim of this review is to
describe the status quo regarding both aspects, through a
comprehensive assessment of the contemporary literature on
bioactive NPs. The present report summarizes over a decade of
data-mining activity by the authors, which involved manual
screening of >80000 pages of scientiﬁc literature during the
periods 1998−1999, 2004−2005, and 2009−2010. To date,
data have been extracted from nearly 2000 peer-reviewed
articles, forming the foundation of this survey of analysis and
puriﬁcation of bioactive natural products (AnaPurNa). The
framework of this study was designed at the survey onset and in
a prospective fashion. Throughout the study, the literature was
examined for a set of predeﬁned parameters, which were
Figure 1. Progression of NP puriﬁcation from a metabolomic mixture. The process involves repeated (n-times) preparative- and analytical-scale
separation and, depending on the methods and n, results in a NP that is linked to varying residual complexity (RC), reﬂecting both its metabolomic
heritage and the puriﬁcation protocol. Subsequent analytical characterization including purity assessment is required to generate a fully quality
controlled NP (cNP) or single chemical entity (SCE, Figure 2). The nearly 2000 publications evaluated employ bioassays to address screening of
crude NPs, bioassay-guided fractionation, biological assessment of puriﬁed NPs, and detailed pharmacological investigation of, for example,
structure−activity and structure−purity relationships (SARs and PARs, respectively; see text and Figure 2).
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also had to fulﬁll certain inclusion and exclusion criteria.
Furthermore, a set of 15 questions to be answered was
developed at the beginning of the study. These questions are
addressed individually in the discussion of the observations
made below.
This review is organized as follows: the methodology section
describes the data-mining methodology employed as well as the
journal and time coverage of the survey. Subsequent sections
present the survey results as well as the numerical and statistical
measures developed from these data. The next section
concentrates on the following aspects: sources of puriﬁed
NPs; chromatographic methodology used for NP isolation;
spectroscopic methods used for NP characterization; and the
role of purity and the methods used for the purity analysis of
NPs. The ﬁnal section of the review summarizes the ﬁndings
from the perspective of potential new approaches to the
analysis of NP complexity and the achievement of novelty. It
proceeds to point out areas of challenges in chromatography
and spectroscopy. Final discussions are devoted to the role of
NP integrity including purity and linkages between chemical
and biological properties of bioactive NPs. The integration of
these aspects potentially could help in advancing the future role
of NPs as a viable source of new biologically active agents.
■ METHODOLOGY
Data-Mining Procedures, Journals, and Time Period
Coverage. The source journals (n = 13), intervals monitored
(1998/1999 [period I], 2004/2005 [period II], 2009/2010
[period III]), and coverage of evaluated articles (ntot = 1823)
are summarized in Table 1. All journals screened are well-
established and peer-reviewed and dedicated to or frequently
publish studies on bioactive NPs. They are focused on drug
discovery and/or pharmacology involving NPs and exhibit a
wide range of ISI impact factors (ca. 0.4 to 4.0).
In the initial stage, the survey consisted of a large-volume
screening of reports from both years of period I, which involved
manual screening of ca. 55000 journal pages from 12 journals.
Upon compilation and preliminary data evaluation, this led to
the selection of six priority journals and the addition of one
journal (Journal of Asian Natural Products Research)f o r
continuation of the survey in the subsequent periods II and
III, which mostly focused on one year of the two-year periods
(see Table 1 for details). The seven priority journals were
selected due to their much higher information density, i.e., the
number of qualifying articles. Accordingly, the number of
published pages to be screened was reduced to ca. 15 000 and
about 12 000 pages in the periods II and III. Of the journals
with a lower prevalence of qualifying reports, one (Journal of
Pharmacology and Experimental Therapeutics) was included with
the seven priority journals and assessed for the entire period
2000−2003 (n = 77; not included in ntot) plus one year of
period II, in order to provide an example of extended coverage
for these journals.
Inclusion and Exclusion Criteria. For any given journal
volume included in the study, all articles were prescreened
manually for the following inclusion criteria: they had to report
on both bioactivity and chemistry of NPs and provide a
substantial experimental description, regardless of how well the
NP-related portion was developed. Exclusion criteria were as
follows: reports in which bioactivity was clearly a minor aspect
of the work; reports in which NP and/or synthetic chemistry
was so dominant that the bioactivity portion was insigniﬁcant;
and reports with ambiguous experimental descriptions of the
analytical parameters. By default, only full papers generally were
included. However, depending on the journal and its editorial
framework, in some instances such as limited coverage of a
given volume or year, publications in content-limiting formats
(e.g., Notes) that fulﬁlled the other inclusion criteria and had a
suﬃcient level of detail to address the key study parameters
were included in the survey. By ensuring that formatting
restrictions did not impact the scores, these added publications
contributed to the statistical signiﬁcance of the survey by
increasing the total number of articles evaluated.
General Methods. The raw data were collected into tabbed
spreadsheets (Microsoft Excel 2010) and analyzed using
Table 1. Source Journals, Time Periods, and Coverage
a of the Survey
period I period II period III
1998 1999 2004 2005 2009 2010
journal (group)
a vol.
c no.
c vol.
c no.
c vol.
c no.
c vol.
c no.
c vol.
c no.
c vol.
c no.
c
sum (year) 342 374 377 125 172 260
Biological Pharmaceutical Bulletin (A)
b 21 24 22 32 28 125 33 85
Chemical Pharmaceutical Bulletin (A)
b 46 25 47 27 52 52 57 66
European Journal of Pharmacology (B)
b 341−364 10 264−386 23
Fitoterapia (B)
b 69 7 70 8 75 19 81 88
Journal of Asian Natural Products Research (A)
b 6 8 11 58
Journal of Ethnopharmacology (B)
b 60−64 11 65−68 11
Journal of Natural Products (A)
b 61 83 62 99 67 198 72 64 73 194
Journal of Pharmacy and Pharmacology (B)
b 50 13 51 11
Journal of Pharmacology and Experimental
Therapeutics (B)
b,e 284−287 3 288−291 11 309−311 8
Phytochemical Analysis (B)
b 9 1 10 3
Phytochemistry (A)
b 47−49 64 50−52 63 65 79 70 42
Phytotherapy Research (B)
b 12 38 13 21
Planta Medica (B)
b 64 63 65 65 70 21
d
antot = 1823.
bJournals were assigned to two groups, A and B, according to the depth of reported spectroscopic information (see Methods section
and main discussion for details).
cThese two columns give the journal volume number and the number of articles that fulﬁlled the inclusion criteria
and were evaluated, respectively.
dOnly 21 articles were assessed, although about 80 articles would have fulﬁlled the inclusion criteria.
eOnly this
journal was assessed for the period 2000−2003 (n = 77; not included in ntot).
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conditional formatting functions of the software.
Prospective Setting of Parameters. The parameters
extracted from the primary literature, as well as the scoring and
key system used to record the information in a standardized
spreadsheet format, resulted from a preliminary, randomized
screening of ca. 100 articles and were deﬁned before starting
the main survey. As a means of prospective guidance for the
data-mining process, all of the questions addressed under the
Observations Made section of this review were also formulated
at the onset of the study. While the insight gained during the
study led to additional hypotheses that were eventually tested
with the complete survey data, the scores initially implemented
and keys as well as the basic set of questions were maintained
constant during the entire study.
Collected Basic and Compound Information about
the Reported Bioactive NPs. In addition to the basic header
information about each article (author name, journal volume,
page), the primary biological activity or target of each report
was recorded. Furthermore, for each report, the total number of
NPs and the predominant class of compounds were recorded,
and the following data were determined: total number of
compounds; number of compounds that were isolated by
puriﬁcation from natural material; number of compounds that
were synthesized (full or partial); number of compounds that
were gifts from colleagues; and the number of new structures.
Scoring and Key Systems for the Evaluation of
Isolation and Spectroscopic Methods. The experimental
section of each report was evaluated for parameters that reﬂect
the methods used for the puriﬁcation of the NPs and their
spectroscopic characterization. As many reported isolation
procedures are rather convoluted, the assessment included
determination of the longest puriﬁcation pathway and the
highest degree of diversiﬁcation of the methods employed. The
maximum number of isolation steps was counted, excluding
extraction and solvent partition procedures. The use of normal-
phase silica gel as a primary or secondary puriﬁcation step, after
any partitioning or precipitation steps, was recorded as a binary
number. In addition, the diversity of the puriﬁcation methods
was assessed and encoded into binary format as a byte integer,
consisting of the following ﬁve bits: 0 = undeﬁned or literature
reference only; 2° = precipitation or crystallization; 21 = paper
or thin-layer chromatography (TLC), including centrifugal
TLC; 22 = column liquid chromatography (LC), vacuum LC,
and low-pressure LC, and the value 21 was added to encode
repetition in the entire scheme; 23 = medium-pressure and
high-pressure LC (MLPC, HPLC), and also the value 21 was
added to encode repetition in the entire scheme; 24 =
countercurrent chromatography. The reported LC techniques
applied numerous diﬀerent solid-phase packings, which were
not individually diﬀerentiated in the survey and included
primarily the following: normal- and reversed-phase (RP-8/18;
cyano) silica gel; SephadexL H - 2 0( s e er e f1 0f o ra
comprehensive review); styrene resins (see ref 11 for theory
and applications).
Data collected on the spectroscopic characterization of the
NPs, for which bioactivities were reported, included the
number of compounds for which spectroscopic data were
reported, the comprehensive nature of the general physical/
spectroscopic data in general, and, separately, the nature of the
NMR data utilized in particular. For this study, “depth” is
deﬁned by the completeness, detail of interpretation, and
comprehensive nature of data. This was assessed and scored as
follows: for the general spectroscopic and other analytical data,
1 = highly comprehensive (X-ray and/or very comprehensive
1D and 2D NMR, MS, physical data); 2 = comprehensive (1D
and some 2D NMR, MS, physical data); 3 = as for 2 but with
apparent gaps; 4 = mainly or fully lacking; 5 = literature
reference only, or in cases where no spectroscopic data were
reported, or referred to “as previously described”,w i t h
reference to other literature. Similarly, the depth of NMR
data were scored: 1 = highly comprehensive (1D and 2D NMR
and/or special experiments such as selective pulse experiments,
spectral simulation, connection with molecular modeling
studies); 2 = comprehensive; 3 = as for 2 but with gaps; 4 =
mainly or fully lacking; 5 = literature reference only or in cases
where no spectroscopic data were reported. In judging the
completeness of physical data, the reports were considered
adequate despite not providing UV data if the compounds had
no chromophore, and similarly optical rotation was not
expected if the molecules were achiral. For the assessment of
reports from the most recent time period, III, the provision of
spectroscopic data as Supporting Information (SI) was
considered as added comprehensiveness that was linked via
cross-references in the main text. Due to workload and practical
considerations, however, the SI materials were not screened.
Scoring and Key System for the Evaluation of Purity
Assessment. Finally, each article in its entirety was mined for
information about purity assessment of the bioactive NPs. The
information was encoded into binary format as a byte with ﬁve
bits, as follows: 0 = undeﬁned or obscure method; 2° = taken
from vendor label; 21 = single spot on TLC; 22 = determined
by HPLC; 23 = determined by quantitative 1HN M R
(qHNMR) through basic integration using the 100% method;
and 24 = determined by qHNMR with calibration or by
titration, data given for each compound.
Estimation of Human Error in the Evaluation and
Scoring Process. All authors were involved in the data-mining
process, which involved manual page turning of journal hard
copies, judgment of inclusion criteria of each article in the
screened volumes, and mining of the aforementioned data from
each of the 1823 articles. It is realized that the scoring systems
involve an element of subjectivity that may lead to deviations in
scores assigned by individual assessors. Another potential
source of variation was the screening of experimental sections
for data about isolation methods, in particular in reports where
the puriﬁcation procedures were lengthy and/or convoluted.
While the information was mined with particular care and
attention to detail, the extracted data might have deviated
slightly in a few instances; for example, the number of isolation
steps might be oﬀ by one step from the actual experiments.
Given the workload of manually screening 80 000 pages of
literature information, it was not feasible to perform the entire
survey in triplicate and/or by multiple individuals. As no
averaging was performed, the data represent the outcome of
single assessments. The authors distributed their eﬀorts as
assessors across the journals, as this helped by averaging the
inﬂuence of interindividual subjectivity. Moreover, a limited
amount of cross-checking between the authors was also
undertaken.
■ OBSERVATIONS MADE
Data from this AnaPurNa study are presented in the following
paragraphs and are discussed with respect to the questions (Q;
numbered) that were formulated initially in the prospective
study. As the study evolved over the last 10+ years, additional
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added and are included.
Literature Characteristics. NP isolation accompanied by
bioactivity measurement is considered to be the specialization
of a larger discipline. While many journals occasionally publish
articles on the isolation of NPs and their bioactivity, only a few
journals regularly publish such reports. This study is an in-
depth investigation of a handful of journals (limited for
practical reasons) that publish articles routinely on the
bioactivity of NPs, rather than a broad study of the general
literature. This systematic literature review focuses on a
selection of journals that contribute heavily to the specialization
of NP research, with a particular focus on pharmacognosy and
natural products chemistry. Independent of the choice of
journals, it is likely that the editorial policies of the selected
journals inﬂuence the data. This reﬂects the natural ﬂow of
disciplines in science, where areas of specialization form their
own communities and at the same time contribute to the
greater scientiﬁc endeavor in a variety of ways. For example,
puriﬁed NPs may be incorporated into human clinical trials,
which will be published in a medical journal rather than a
natural products journal.
Q1: Is Information on Bioactive Natural Products
Concentrated in a Few Journals? Yes. Seven of the 13
journals (Table 1) represent 79% coverage of qualifying
reports. This number increases to 88% when including the
proportional numbers of qualifying articles in Planta Medica
from periods II and III. The articles assessed were almost
evenly distributed over the time periods I, II, and III, providing
716, 501, and 597 surveyed reports, respectively.
Q2: Which Journals Are the Major Sources of NPs
Bioactivity Information? When ranking the journals by
number of qualifying articles, about one-third of them were
published in the Journal of Natural Products. Following in the
ranks are Biological/Chemical and Pharmaceutical Bulletin
(combined), Planta Medica, Phytochemistry, Fitoterapia, and
the Journal of Asian Natural Products Research. The latter was
included in the survey for period III, in order to get a
perspective on a publication that reﬂects the outlet of the very
productive NPs research community in Asia. A graphical
overview of the journals by contributed survey articles is
provided in Figure S1, Supporting Information.
Sources of Puriﬁed NPs. There were four main sources of
the NPs: (i) isolation and puriﬁcation of the NP by the authors
as reported in a scientiﬁc publication; (ii) purchase of NPs from
commercial sources; (iii) receipt of NPs from colleagues who
have performed the isolation and puriﬁcation themselves; and
(iv) (semi)synthesis.
Q3: What Is the Role of Gifts and Synthetic Test
Compounds? The proportion of bioactive NPs that were
described as gifts from colleagues has dropped over the survey
time period from 1.6% in period I to 0.7% in period II and 0.6%
in period III. Looking only at the group A journals, gifts were
reported for around 1−2% of all investigated NPs (0.6% in
period I, 2.5% in period II, 1.1% in period III) and, thus,
contribute to only a very small proportion of the studies. The
overall reduction in shared compounds might be a result of the
trend toward smaller isolation yields and their consumption in
the bioassays, together reducing the availability of the
compounds. These observations are also in line with an
observed trend toward collaborative research, which indicates
that teams involving NPs researchers produce compounds
dedicated to biological evaluation. This again may result in the
unavailability of the compounds for subsequent studies.
Recently, some journals have implemented requirements for
the inclusion of copies of original spectra as Supporting
Information, which facilitates structural dereplication by other
researchers. At the same time, this new mechanism may
contribute to the observed reduction of sharing of the actual
compounds among researchers.
The involvement of synthetic NPs has seen a signiﬁcant
decline, by 75%, over the study period: while they contributed a
similar proportion of study compounds in period I in all
journals (11.9% in journal group A, 7.9% in journal group B),
their overall contribution to all study compounds decreased
from a relatively high 9.5% in period I to 6.3% in period II and
2.8% in period III in the group A journals and from 11.5% in
period I to 6.5% in period II and 3.1% in period III when
adding both groups A and B together. This shows that the role
of (semi)synthetic chemistry in the surveyed journals has
diminished over the observation period.
Q4: What Is the Role of Purchased Test Compounds?
What Role Do Commercial Suppliers Have in Pharmacol-
ogy-Oriented NPs Research? Addressing this question
eventually required a more elaborate analysis of the data,
including diﬀerentiation by looking at individual journals and
the groups of journals. In this study, it was determined that the
vast majority of NPs used in bioactivity studies were isolated
and puriﬁed by the authors from their natural sources by the
protocols described in the experimental section included in the
publication. The average proportions of puriﬁed NPs across all
journals rose from 78% in period I to 93% in period II and 95%
in period III. The main reason for both the high proportion and
the rise may be that the probability of a major or even
breakthrough discovery is lower with a compound that has been
extensively investigated due to its unrestricted (commercial)
availability. However, dividing all journals into two groups, A
and B, according to the overall depth of spectroscopic data (see
Methodology section, Table 1, and details below) reveals a
diﬀerent trend: while in group A, ca. 85% of compounds
reported in each journal were isolated and characterized, their
proportion in group B is only about 55%. This means that in
the group B journals ca. 45% of NPs are purchased, gifts, or
synthesized compounds. Considering that gifts and synthetic
substances are generally minor sources of NPs, this implies that
the amount of purchased NPs has increased in the group B
journal reports. These interpretations are supported by the
analysis of all 12 journals from period I: only 3.5% of NPs
(107) reported in the group A journals were from commercial
sources, but their proportion in the group B journals was 6
times higher, at 22% (305). For one group B journal (Journal of
Pharmacology and Experimental Therapeutics)a n a l y z e di n
period II, the proportion of commercial NPs was 47%.
Conversely, in group B the proportion of isolated/characterized
compounds was as low as 36% in reports within an individual
journal. These observations regarding the sourcing of the
investigated NPs are independent of diﬀerences in scope and
policy of the journals in groups A and B and also of the diverse
foci (e.g., chemistry or biology orientation) of individual
reports.
The high percentage of bioactive NPs that are isolated and
characterized (currently about 95%) also indicates the rarity of
puriﬁed NPs in that most researchers tend to produce these
compounds by themselves rather than obtaining them
commercially. This observation is important, because one
consequence of this practice is that the authors themselves are
Journal of Natural Products Review
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its purity as well. In cases where NPs are obtained from
commercial sources, the isolation process may well be
proprietary; however, the NPs will also carry a speciﬁcation
sheet, certiﬁcate of analysis, and/or certiﬁcate of origin that
includes a purity statement conforming to the standards of the
manufacturer.
The percentage of reports on new chemical entities has been
remarkably stable over time. In the group A journals, an average
of 30.1% of reported NPs were new chemical entities (30.2% in
period I, 26.5% in period II, 31.0% in period III), which
represents a 4-fold higher incidence than in group B. Since the
beginning of the survey, the reports in one journal (Fitoterapia)
included in the seven priority journals have shown a signiﬁcant
increase in new NPs and today closely match the average of the
group A journals (28.3% in period III).
Considering this further, in most cases the principal division
of labor in the surveyed reports is the sharing of responsibilities
between the NP chemist performing the isolation and the
biologist completing the bioassay work. This means that at a
certain point the isolated NP(s) are handed oﬀ from a NP
laboratory to a biology laboratory. In this case, unless activity-
guided chromatographic fractionation is conducted, it seems
that the investigations will almost always be chemistry driven,
so that the chemist will select the most interesting and
accessible NPs to isolate. Typically, the bioactivity of the crude
extract was reported along with the bioactivities of the ﬁnal
isolation product(s), while the potency of fractions throughout
the separation scheme was reported much less frequently. It is
important to monitor the activity of NPs (extracts, fractions,
puriﬁed compounds) through at least three puriﬁcation steps in
order to establish the correlation between chemical purity and
biological activity. Purity−activity relationships (PARs)
12 are
quantitative correlations between chemical (purity) and
biological (potency) parameters, which indicate whether or
not the observed biological activity can be attributed to the
main component, assigned as active principle. As such, PARs
can be helpful indicators for prioritization. Considering the role
of purity in the literature, as observed in this study, this type of
information might currently be under-utilized. Notably, PARs
can also be established at the level of puriﬁed compounds (NPs
and cNPs; Figure 1), e.g., by comparing the potencies of the
same NP puriﬁed from diﬀerent sources and/or by diﬀerent
puriﬁcation protocols. Another measure of the importance of
the biological component may be how many NPs that produce
promising “hits” in the biological assay are investigated further
for their biological activity. This interface between NP
chemistry and biology is crucial to the ongoing success of
this specialization, which seeks to harmonize these two aspects
of scientiﬁc research.
Chromatographic Methods for NP Puriﬁcation. Today,
numerous chromatographic procedures with widely diﬀering
characteristics (selectivity, mechanism, resolution, loading
capacity, scale-up behavior) are available to the NP researcher.
The chromatographic information extracted from the surveyed
literature provides insights into the ongoing use of this diverse
toolbox. The binary encoding and scoring of characteristics of
the puriﬁcation methods used in surveying all reports is
described in the Methodology section and rests on a thorough
case-by-case analysis of the experimental section of each report.
Considering the correlation between the metabolomic
complexity of crude extracts and the residual complexity of
puriﬁed NPs (Figure 1), the codes and scores were designed to
provide metrics to answer questions about the depth and
diversity of isolation procedures as they are used in laboratory
practice.
While the number of NPs per individual report varies
considerably, the average number of NPs per report has
increased slightly over the survey time period as follows: 6.6 ±
7.3 (SD) in period I, 6.1 ± 5.8 in period II, and 7.8 ± 7.7 in
period III. An upward trend is also noticed for the proportion
of new NPs, which has increased by more than half from 26%
in period I to 37% in period II and 41% in period III. It is
noteworthy that this observed trend applies primarily to
journals in which reports include a comprehensive coverage of
the spectroscopic data (group A journals and Fitoterapia; see
Table 1 and discussion below).
Q5: What Is the Average Number of Isolation Steps to
Yield a “Pure Compound?”. One signiﬁcant outcome of this
literature analysis is the revelation that the average number of
steps taken to isolate and purify a natural product is less than
three (n = 1823). In addition, this number has not changed
signiﬁcantly in the time period covered by the study. In period
I, an average of 2.0 isolation steps (SD 1.7) was used to yield a
“pure” NP. This increased to 2.4 in period II (SD 1.5) and 2.7
in period III (SD 1.6). Taking into account that 22.9% of
reports did not employ any isolation steps (assigned value of
0), the other studies employed an average of three isolation
steps. The data ﬁt a Gaussian normal distribution reasonably
well (Figure S2, Supporting Information), with a tail toward
higher numbers representing the very few studies (n = 39,
0.6%) that employed six to 10 isolation steps. One conclusion
from this data is that compounds that can be isolated in three
steps or less are the predominantly isolated NP. On the other
hand, this observation also indicates that compounds present in
very small amounts and/or similar to more abundant congeners
are currently rarely pursued, likely because they are more
arduous to isolate. An interesting example of this is that
ginkgolides A, B, C, and J have been reisolated from Ginkgo
biloba L. (Ginkgoaceae) hundreds of times, while ginkgolides L
and M are described in only one publication.
13 Recently, the
two new ginkgolide congeners P and Q have been isolated in
less than 30 mg quantities from 8 kg of G. biloba leaves.
14
Q6: How Much Eﬀort Is Required to Isolate a Bioactive
NP? This question includes two aspects: the number of steps is
addressed here, and the chromatographic methodology in the
following section. About half of all reports (48.8%) either did
not perform an isolation or employed only one or two steps to
produce the bioactive NP. Isolation eﬀorts included a maximum
of three steps in about three-quarters of all reports (76.3%).
Publications that described at least four or ﬁve isolation steps
contributed to 23.7% or 7.2% of studies, respectively, and, in
turn, can be considered in-depth isolation studies. There was no
clear trend of their prevalence over the survey periods I/II/III,
with 21.8/18.1/30.8% and 6.8/5.4/9.0% of ≥4- and ≥5-step
studies, respectively.
The eﬀo r tr e q u i r e dt oa c h i e v es i n g l ec h e m i c a le n t i t y
parameters for an isolated NP depends on many factors,
including (i) the concentration of the NP in the crude material
(the higher, the easier the puriﬁcation); (ii) the physicochem-
ical characteristic of the compound, in particular solubility
(precipitation) and tendency to form crystals (a historically
important property of NPs); (iii) the “match” between the
selectivity characteristics of the chosen puriﬁcation methods
and the NP (some methods appear to work better than others
for certain compound classes or types of source materials;
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NPs); and (iv) the nature of the matrix components in the
crude NP, which may cause diﬃculties in the puriﬁcation
process (e.g., polyphenols or chlorophyll in plants, high-polarity
overlap with primary metabolites and other polar substances in
the case of marine NPs). Accordingly, a one-step isolation
procedure might be suﬃcient to purify a NP that is present at
relatively high concentration, i.e., in the 0.2% range (relative to
dry weight of the biomass) and above. During this survey,
numerous examples of such rapid access to a puriﬁed NP were
noted in the literature. They involve typically solvent
partitioning and just one step of normal-phase silica gel column
chromatography, sometimes followed by precipitation or
crystallization. Examples well-known to the authors are vitexin
from Vitex agnus-castus (0.1−0.2% content) and xanthorrhizol
from Curcuma xanthorrhiza (>0.2% content). As the
information about purity in the literature has generally been
very scarce (see below), there is very little basis for judgment of
the properties of these kinds of materials and its impact on the
biological activity. Given the long history of NPs research, it
appears to be likely that more elaborate isolation schemes could
produce new insights and novel structural and biological
information, in particular when performing research on NPs
that have previously been (extensively) studied.
Q7: What Is the Preferred Methodology of Isolation? On
the basis of the entire data set (n = 1823), about two-thirds of
all studies utilize normal-phase silica gel for the isolation of
NPs. The proportion of these studies has increased over the
observation period from 57% (I) to 63% (II) and recently 71%
(III). Interestingly, studies that use normal-phase silica gel
report isolation of crystalline compounds 2−5 times more often
than studies that do not use this sorbent. Comparing studies
that use normal-phase silica gel with those that do not, the ratio
of the average number of crystalline compounds per study was
2.0 in period I, 2.6 in period II, and 4.9 in period III. In the
same time interval, the proportion of crystalline isolates has
declined from 10.1% to 7.3% and recently 4.9%, respectively.
Overall, this may attest to the ability of normal-phase silica gel
to concentrate and/or remove unwanted constituents and oﬀer
one reason for its steady popularity. Its widely known
disadvantages such as irreversible absorption or degradation
of desirable constituents are less frequently conveyed for
bonded silica gel derivatives. Assessment of the actual impact of
these unpredictable properties of silica gel-based stationary LC
phases on the outcome of the puriﬁcation protocol requires
dedicated studies. One such example has been reported by
Pinel et al.,
15 who directly compared normal-phase silica gel
and liquid only based LC (countercurrent separation) for the
puriﬁcation of xanthanolides from Zanthium macrocarpum
(Asteraceae). One intriguing ﬁnding was the ca. 13-fold
reduced yield of one particular xanthanolide, xanthatin, when
using the solid-phase method. This almost selective removal of
a compound from a crude NP might inspire future develop-
ments and/or validation of silica gel-based puriﬁcation
methods.
With regard to the generation of crystalline NPs, it is
noteworthy that their proportion has dropped from 10.1% to
recently 4.9%. This may reﬂect the trend to smaller starting
amounts of biomass and isolation yields based on the capability
of modern spectroscopy to obtain structural information from
smaller and/or less pure samples. These observations are in line
with a conclusion recently made by Meyer and Imming,
16
underscoring the value of practical skills in compound
crystallization for contemporary research programs that involve
puriﬁcation of NPs and other drug leads.
Considering the extremely wide use of normal-phase silica
gel, it is not surprising that one- to two-third of studies (63.7/
35.5/32.5% in the periods I/II/III, respectively) used gravity-
driven column chromatography exclusively. While this propor-
tion is declining, the data show that a large proportion of
isolation procedures are uniform rather than diverse. Likely the
most prevalent isolation methodology consists of normal-phase
silica gel, (repeated) gravity-driven column chromatography,
and HPLC. This combination was found to also increase in
popularity and has most recently been employed by almost
one-half of all studies (27.4/36.1/45.6% in the periods I/II/III,
respectively). These observations may reﬂect preferences for
fast approaches such as automated ﬂash chromatography and
preparative HPLC and/or may also be a sign of the increased
availability of such equipment. Although not speciﬁcally tracked
and encoded in this survey, a general observation is the very
frequent use of C18 reversed-phase silica gel and Sephadex LH-
20 as stationary phases for LC puriﬁcation of NPs. Both
materials are signiﬁcantly more costly than normal-phase silica
gel, which might explain their relatively lesser use, but they have
the advantage of being reusable. Reversed-phase silica gel
appears to be the second most widely used stationary phase and
like normal-phase silica gel is widely employed in (semi)-
automated LC applications such as HPLC, MPLC, and vacuum
and ﬂash LC (including high-throughput settings
17).
In the present meta-analysis, NP puriﬁcation schemes have
two primary dimensions: the number of puriﬁcation steps and
the chromatographic methodology used in each step. While
together they describe the overall depth of the puriﬁcation
process, a chemically diverse metabolome likely requires a
chromatographically diverse puriﬁcation scheme for the
eﬃcient mining of NPs. The binary scores given in this study
for the diversity of the puriﬁcation methods (see Methodology)
allowed us to study the relationships between the number of
steps and the chromatographic methodology (see scatter plot,
Figure S3, Supporting Information). A general observation
from the distribution of the puriﬁcation diversity scores is that
an increase in the number of puriﬁcation steps does not
necessarily indicate an increase in chromatographic diversity.
The data exhibit the presence of general trends, as follows: two-
step procedures mostly consisted of two LC steps (often
repeated) or a combination of one LC and one HPLC step.
Three- and four-step procedures frequently applied repeated
LC and one level of HPLC, although a relatively large number
of these puriﬁcation schemes apply gravity-, vacuum-, or low-
pressure-driven LC methods only.
Emerging from the authors’ research and interest in
countercurrent separation (CS; syn. CCC; see ref 18 for a
review), this survey also explored how widespread the use of
this methodology is. In all studies and over the entire survey
period, countercurrent methods such as HSCCC, CPC, and
DCCC are used only sporadically (average 0.9%). In fact,
despite recent developments of countercurrent technology, its
proportional use in studies on bioactive NPs has actually
decreased over the project period, from 1.7% in period I to
0.3% in period III. Even when looking only at in-depth isolation
studies (see above), the proportion of countercurrent
chromatography use fell from 4.5% in period I to 0.5% most
recently. However, the number of reports that employ
countercurrent techniques and fractionate NPs in-depth, by
using at least three (58/67/50% in periods I/II/III, average
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average 66.7%), is high. This implies that countercurrent
methodology is applied primarily in more complex isolation
schemes rather than as an alternative to other techniques.
These observations reﬂect the need for specialized counter-
current chromatography equipment, which might not be widely
available even to well-equipped laboratories. Another consid-
eration is that, unlike many (semi)automated solid-phase LC
methods (e.g., preparative HPLC), countercurrent separation
techniques require some time to be optimized. While this may
be perceived as being disadvantageous, signiﬁcant progress has
been made recently on key aspects such as solvent system
selection, instrument design, and operation modes, and there is
a wealth of recent reports on eﬃcient NP puriﬁcation protocols
that employ countercurrent techniques (see ref 18 and
references therein).
Q8: Is There a Preference for Well- and/or Long-
Established Techniques? Following from the observations
made in Q7, the uniformity of isolation approaches may also be
due to the fact that this systematic literature survey looked at
only a limited number of journals. For example, there are
dozens of articles published every year featuring the isolation of
NPs with countercurrent separation with subsequent analysis of
bioactivity. These articles are typically published in chromatog-
raphy journals rather than NP publications.
19−21 Similar
considerations apply for supercritical ﬂuid separations. That
having been said, the use of normal-phase silica gel as a
chromatographic method of choice is much more entrenched
than can be simply explained by the fact that some alternatives
are considered to be specialized techniques. The reported use
of normal-phase silica gel has actually increased during the time
period of this literature survey.
Numerous preparative-scale analytical methodologies are
used in minor compound puriﬁcation in the laboratories of NP
researchers. Owing to the complexity, newly developed
techniques are often “test driven” in NPs laboratories. Examples
are the development of countercurrent chromatography, as
pioneered by Y. Ito and co-workers,
22,23 and the advent of
HPLC in the 1970s.
24 While a few techniques have established
themselves as mainstream, it remains unclear as to what other
techniques have to oﬀer and what roles they can play in the
future.
Spectroscopic Methods for NP Characterization. Once
a NP has been isolated from its metabolomic background
(Figure 1), characterization of its chemical structure
(veriﬁcation, dereplication, or elucidation) is the next step
toward a quality-controlled material (cNP, Figure 1) for
biological evaluation. The questions posed were as follows:
Q9+Q10: What Is the Level of Analytical Detail Provided
for the Tested Bioactive NPs? Considering Available
Instrumentation and Methods, What Is the Depth of the
General Spectroscopic Data? In order to answer these
questions, both the physical data in the experimental sections
as well as the tables and descriptions in the main text of the
articles were assessed, and the extracted information was coded
as previously described under Methodology. The criteria took
into account the widespread availability of spectroscopic
equipment (NMR, MS, UV, IR, less so CD/ORD). While
the depth of spectroscopic analysis per se is scientiﬁcally
independent, editorial policies and journal format constraints
undeniably have an impact on the information ﬁnally reported
and, very possibly, which experiments are performed. There-
fore, to apply equal measures in the entire survey, the same
coding scheme was applied to all publications and across the
survey time period.
Compounding the scores for the depth of spectroscopic data
for all articles (n = 1908) yielded a numerical average of 2.5 on
the discrete scale from 1 to 5 (lower number better; see under
Methodology). Thus, on average, the spectroscopic foundation
of all reported bioactive NPs (ncpd = 12 570) was between
“comprehensive” (2) and “with gaps” (3). The distribution of
the scores (S4, Supporting Information) shows “tailing” toward
higher scores, as a result of 21.9% of the reports lacking support
by spectroscopic characteristics at all (13.3%) or in the same
publication (8.6%). In relation to the NPs, spectroscopic data
were provided for less than half of all compounds (5510 =
44%), with only minor diﬀerences over the 12-year survey
period.
When analyzing reports by journal source, the distribution
and average depth of spectroscopic information in the 13
surveyed journals were heterogeneous. This is not an
unexpected outcome for a number of possible reasons already
discussed above. In fact, when evaluating the depth scores of
both general spectroscopic and NMR spectroscopic data for the
entire survey period, a clear gap was noted between average
scores of 2.5 and 3.0, as can be seen in the tables and graphs in
S5 and S6 of the Supporting Information, respectively. This led
to the classiﬁcation of the journals into the groups A and B
(≤2.5 [ﬁve journals] vs ≥3.0 [eight journals], respectively; see
also Table 1). The ﬁve group A journals showed an average
score of 2.1 and covered greater than four-ﬁfths (10660 =
84.7%) of all studied bioactive NPs. Conversely, reports of less
than one-ﬁfth of the compounds (1827 = 14.5%) were in the
group B journals, which gave an average score of 3.8.
Considering that about one-ﬁfth of the reported NPs lack
support by spectroscopic characteristics (see above), the
distributions of the spectroscopic depth scores in the two
journal groups are almost mirror images of each other (S5,
Supporting Information). Analogous observations were made
for NMR spectroscopic data, which is usually essential for
structure elucidation and compound identiﬁcation. Of the
seven priority journals selected for long-term surveillance over
the whole 1998−2010 period, ﬁve were group A journals.
Q11: Considering Available NMR Instrumentation and
Methods, What Is the Depth of NMR Spectroscopic Data?
The total average depth score (see Methodology section) for
the NMR spectroscopic data (2.7) is almost identical to that of
the general spectroscopy (2.5). The two sets of spectroscopic
depth measures also show parallel behavior over time and have
experienced a steady improvement over the three survey
periods: from 3.3 to 2.3 for the NMR and 3.1 to 2.0 for the
general spectroscopic data. This can be seen clearly from the
score distribution plots provided in S7, Supporting Information.
These results indicated that NMR spectroscopy in general and
2D-NMR, in particular, have become the mainstay of structure
elucidation. The observation that in the most recent period, III,
49% of all NPs were reported with NMR spectroscopic
information categorized as “comprehensive” and an additional
18% as “highly comprehensive” can be interpreted as a sign of
strong NMR evidence for the structure of about two-thirds of
all bioactive NPs. These encouraging observations, however, do
not necessarily indicate that dereplication of two-thirds of all
NPs is straightforward. While the scoring system was not
designed to speciﬁcally address this question, it is the authors’
impression that unambiguous dereplication requires (NMR)
spectroscopic data sets that scored typically as one in this
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conclusions about the level of detail that is needed and/or
practical for structure dereplication and, thus, full reproduci-
bility, the survey indicates that NMR spectroscopy has been
playing an increasingly strong role in this regard.
What has changed over time is that the NMR spectra are
now included as Supporting Information in most journals,
especially in the case of new compounds, due to space
constraints. Unfortunately, the depth of the NMR data cannot
be assessed in many cases simply because the spectra are not
available. One way to assess depth of NMR data is level of
detail, such as the completeness of the assignments, the
coupling pathways, the coupling constants, and the multiplicity
assignments. In addition, not only may structural data be lost
but valuable information on the purity of an isolated NP may
be disregarded by consigning NMR data to a table or brief
listing. Another way to assess the depth of structural
information is to consider the number and sophistication of
the spectroscopic tests that are reported. For example, 2D
NMR techniques generally reveal more structural subtleties
than can typically be deduced from 1D 1H and 13C experiments
only. This brings up an important point of the sophistication of
both the technique and the individual who interprets the data.
Two scenarios present themselves: a rather simple technique in
the hands of a skilled researcher can reveal structurally accurate
conclusions, while a sophisticated technique may be poorly
interpreted and even misinterpreted. All in all, the depth of
structural information relies on what constitutes an adequate
attempt to assign a structure to a given compound. With NMR
prediction and simulation techniques becoming more main-
stream (see refs 25, 26 and citations therein), it is possible that
computational analysis of NMR spectra may be encouraged in
the future as supporting or possibly even deﬁnitive evidence of
a correct spectroscopic interpretation.
Role of Purity and Methods for NP Purity Assessment.
The role of purity is typically, but not necessarily (see
discussion below), assessed last in the NP isolation workﬂow
(Figure 1). Ideally, the purity of quality-controlled NP for
biological evaluation is high, making it a single chemical entity.
The four initial survey questions regarding purity were
addressed as follows.
Q12: How Frequently Is Information on Compound Purity
Reported? The short answer is that reports occur rather
infrequently and at a declining rate. Compounding the
information for all journals and sorting by survey period, the
topic of purity is only addressed (not necessarily measured) in
4.6−8.4% of the reports (6.3% total average). Over time, purity
reporting has been on a decline and was found in only 31 of
597 reports evaluated in the most recent period, III (5.2%).
Interestingly, when considering the whole survey period, 4.2%
(76) of reports from the group B journals address purity vs
1.4% (26) reports in group A. Assuming a general awareness of
purity as a parameter, it is possible that some studies
determined purities without publishing this information, but
there was no way of determining the abundance of such cases.
In summary, purity analysis was reported as being performed
for less than 10 in 1000 compounds, and HPLC or more
elaborate methodology was used for less than ﬁve in 1000.
Q13: What Is the Role of Labeled Purity? It is important to
diﬀerentiate between awareness and actual assessment of
purity: an average of 3.6% of all reports included some form
of purity analysis, and the rate has been declining over the
survey period (4.6% to 3.2% to 2.8% in periods I, II, and III,
respectively). The diﬀerence between “purity addressed” and
“purity assessed” (6.3% vs 3.6% of all reports) suggests that
about 40% of reported purity information is taken from
(vendor) labels or derived from undocumented or otherwise
obscure methods.
Q14: Is HLPC the Preferred Method of Purity Determi-
nation? In contrast to the declining awareness of purity, the use
rate of HPLC for purity analysis is ﬂat over the survey period
(2.2−2.4%): An average of 2.3% of reports, representing about
one-third of all reports surveyed, used HPLC for this purpose.
Accordingly, HPLC is the most common method of purity
measurement when purity is reported. Ostensibly, this is done
because an HPLC method was developed as part of the
isolation scheme to either prepare the target NP(s) or assess
the purity of fractions. HPLC provides the chromatography
method, and the detector actually monitors the composition of
the column eﬄuent. The UV−vis method of compound
detection is used widely in HPLC and other liquid
chromatography methods. It can be a highly sensitive method
to detect and quantify a target compound and has the potential
to be universally applied to NPs that involve a UV−vis HPLC
method at some stage of the puriﬁcation protocol. On the other
hand, this method often has severe limitations in detecting
sample impurities. More sophisticated methods of LC detection
are available,
27 including MS(−MS), ELSD, and corona
charged aerosol detector, and used for this purpose. These
methods all are limited to varying degrees in that they have
Figure 2. Connectivities between bioactive NPs and biological test
systems. A “pure” NP ideally represents a single chemical entity
(SCE). Its interaction with a deﬁned biological target (T) establishes a
deﬁnite structure−activity relationship (SAR) and typiﬁes how the
majority of bioactivities of NPs are characterized. However, due to
variation in puriﬁcation protocols and their source, NPs are inevitably
(→ chain) impure proﬁles, by virtue of residual complexity (RC) from
the source organism’s metabolome. Similar considerations apply to the
bioassay: whole cell assays in particular entail the entirety of biological
targets and processes (biome) with which the NP sample interacts.
Interactions between the SCE and/or the RC and the biome can lead
to a response and need to be considered when interpreting outcomes.
Depending on the proportions of SCE and RC and the interactions
with T and the biome, the SARs and purity−activity relationship
(PAR) of a NP will interfere, with possibly profound impact on the
outcome.
Journal of Natural Products Review
dx.doi.org/10.1021/np300066q | J. Nat. Prod. 2012, 75, 1243−1255 1251altered sensitivity between diﬀerent compounds, and thus
cannot be considered universal detectors and require carefully
tuned parameter optimization. Relevant to purity assays, but
primarily of importance to the metabolomic aspects of NP
research, it shall be noted that recent developments in LC (e.g.,
UHPLC) and hyphenated technology (e.g., LC−MS, LC−
NMR) have signiﬁcantly advanced analytical capabilities for the
characterization of both complex and puriﬁed NPs (see reviews
28, 29 and references therein).
The survey data clearly show that the purity of NPs used in
bioassays is rarely reported. There may be some feeling that if a
NP is pure enough to determine its structure by NMR and
mass spectrometry, it is suﬃciently pure to analyze its
bioactivity. As shown in Figures 2 and 3, this may or may
not be the case, depending on the balance of NP and its RC
component and their interactions with the target and the biome
of the test system. Parameters such as purity, speciﬁcity, and
(residual) complexity are involved in both the chemical and the
biological portions of the analyses, and they play equally
important roles in the outcome. From the chemical perspective,
there can be no question that the purity of a NP is of utmost
importance in determining its bioactivity. At best, an inactive
impurity will dilute the apparent activity that is usually
measured in terms of bioactivity per mass of NP. More
impactful is the possibility that the bioactivity of a minor
component could mask the true bioactivity, or lack of it, for the
target NP. This underscores the importance of following
purity−activity relationships
12 as a way of correlating the
measured bioactivity and the bioactivity of the target NP.
It should be noted that the aforementioned 3.6% rate of
HPLC purity reports only referred to qualifying HPLC
statements, whereas these reports did not include details of
the analytical methods used such as chromatograms, integrals,
and calculations. Elaborate reports of purity were coded
separately and were very rare at a total average of 0.9%.
Moreover, the rate of detailed purity assessment has declined to
levels of 0.20−0.34% in the most recent two survey periods.
Despite research progress and increasing interest in the
methodology, quantitative [1H] NMR (q[H]NMR; see refs 30,
31 for a literature overview) so far has rarely been used for
purity assessment,
8 with only 13 reports, or 0.72%, employing
qHNMR. Interestingly, the survey did not detect any further
use of qHNMR for purity analysis of NPs involved in
bioactivity studies in the most recent time period, III. However,
virtually all investigators today use 1H NMR spectroscopy in
the structural elucidation of their NPs and, therefore, have at
their ﬁngertips the data to determine the purities of the NPs
isolated. Considering that qHNMR methodology is well-
established, purity evaluation using the 100% method is
straightforward from most existing 1H NMR data sets.
Calculation and citation of such data are relatively uncompli-
cated and would add important evidence to the matter of RC
highlighted here, as well as to related discussions about
bioactive NPs.
Q15: What Is the Average Purity of Tested Compounds?
Considering the observation that ca. 40% of reported purities
are taken from (vendor) labels or undocumented methods and
an additional ca. 30% from HPLC statements, the reported
purity values have to be interpreted with caution. In order to
put the small numbers of purity-tested NPs into perspective, of
the total number of bioactive NPs (ncpd = 12570), an average
of seven compounds (SD 7) were included in one report.
Given 102 reports on actual purity analysis by HPLC
(statement) or better, this potentially aﬀected ca. 700 NPs
(ca. 6%). Due to the design of the study, the actual number of
analyzed compounds was not recorded in the periods I and II.
During the literature assessment it became clear that this
number is much lower, likely by a factor of 5 to 10. This is in
line with two other observations: (i) the low (0.1−1.1%)
proportion of compounds in reports with HPLC or better
purity analysis and (ii) that 85% of purity statements contained
Figure 3. Interplay between the purity of NPs and diﬀerent biological test systems. The outcome of testing “puriﬁed” NPs in bioassays that comprise
diﬀerent response elements (biome; Figure 2) can be symbolized by triangles in which proverbial “tips of the iceberg” represent both the well-
deﬁned target (T) of the bioassay and the residual complexity (RC; Figure 2) of the NP, respectively. As purity decreases and RC increases, four
main scenarios, A−D, can be distinguished: (A) highly pure NP, only the SCE interacts with T; (B) like A, but the SCE interacts with additional
biome processes; (C) in a bioassay with reduced speciﬁcity, NPs containing some impurities exhibit intermediate bioactivities, which can result from
all four interactions depicted in Figure 2; (D) in impure NPs, the RC component dominates the biological response, even if T is highly deﬁned. In
addition to A−D, depending on whether only SCE or RC or both components are active principles, three series, 1−3, of biological potency may be
observed. Particularly relevant (marked *) for NPs research are (A1) the ideal case: the puriﬁcation leads to a near pure SCE as bioactive principle;
(C1) false potency: the inactive RC “dilutes” the bioactivity of the SCE such that potency is misjudged; (C2 and D2) false assignment of bioactive
principle: the puriﬁcation yields the active principle, but it is contained in the RC component and not represented by the (apparent) SCE.
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only one or very few NPs were analyzed and/or individual
samples were not diﬀerentiated.
Based on the evaluation of 102 reports, the following can be
said about purity statements: the vast majority of reports (87%)
state purities of “95%” or higher, and almost two-thirds (60%)
of which report purities of “98%” and above. While a few
studies (3%) even report absolute purity (“100%”), the same
proportion reports purities below “80%”. In general, assigned
purity values were mostly given without decimal places.
■ SUMMARY AND CONCLUSIONS
Added Dimensions of Complexity and Potential for
New Approaches. At least three additional dimensions of
complexity aﬀect the interpretation of research data on
bioactive NPs and will be addressed in the following: (i) the
role and relationship of in vivo (here including whole cell- and
animal-based) vs in vitro bioassays used to assess bioactivity in
the NP puriﬁcation and characterization workﬂow (Figure 1);
(ii) the depth and diversity of the puriﬁcation workﬂow; and
(iii) the role of purity and RC. In addition, just as RC is almost
inevitable when purifying NPs, biological test systems are
seldom singleton but rather residually complex or even very
complex entities (e.g., in vivo systems). Potential further
dimensions to consider relate to the connectivity between SCE,
RC, and bioassay (Figure 2), i.e., the speciﬁcity, both qualitative
and quantitative, of the bioassay. Finally, both the bioassay and
the puriﬁed NP may behave like the proverbial tip of the iceberg,
depending on their individual RC characteristics. As a result, a
matrix of scenarios can be conveyed (Figure 3), which reﬂect
the multidimensional interplay of the NP/SCE, its purity, its
RC characteristics, the activities of the SCE and the RC
component(s), and the speciﬁcity of the bioassay. Figure 3
shows that, depending on the combination of these factors,
observations from the lack of bioactivity to the presence of
strong activity potentially can be explained for NPs that
otherwise appear to be identical or at least comparable entities.
Residual Complexity. The importance and potential
impact of RC on, for example, the eﬃciency of drug discovery
workﬂows cannot be underestimated. The initial discovery of
an inverse correlation of anti-TB activity and the purity of
ursolic acid (purity−activity relationships)
12 has led to the
routine integration of qHNMR
30,31 purity assessment in the
authors’ laboratory. A recent report by Fitch et al. describes the
comprehensive eﬀorts aimed at establishing solid structure−
activity relationships for the “frog” alkaloid epiquinamide.
32
Their studies involved chiral synthesis of three and
pharmacological study (nicotinic acetyl choline receptor) of
all four stereoisomers of the NP to eventually determine that all
of them are inactive. The authors state that “the misleading
activity in the natural product material is concluded to be trace
contamination by co-occurring epibatidine”,aﬁnding that
bodes heavily on the relevance of purity−activity relationship
analysis for the validation of NP drug leads proposed earlier.
12
Relativity of Novelty. Cragg and Newman et al.,
1−5 backed
by extensive NPs research experience, stated that “the potential
for the discovery of new chemotypes from plants, comparable
to the taxanes and camptothecins, appears to be relatively
low”.
33 On the other hand, two recent articles by Kinghorn et
al. provide convincing evidence, also backed by long-term
research, for the relevance of higher plants and other terrestrial
organisms as sources for new bioactive lead compounds.
34,35
Emphasizing the exceptional role of camptothecin and Taxol
(paclitaxel), Kinghorn et al. provide a thought-provoking
interpretation that counters the other apparently discouraging
outlook:
33 the possibility that an informative in vitro screen is
not a substitute for a relevant in vivo assay. For the discovery of
ﬁve anticancer leads in the 1970s and 1980s, there was an early
involvement of in vivo testing.
35 However, the insights from the
present AnaPurNa study add yet another possible interpreta-
tion. As the puriﬁcation of highly active principles that are
minor constituents likely requires more eﬀort, it is conceivable
that an increase in the fractionation depth (n, Figure 1) and/or
diversiﬁcation of the preparative-scale separation methodology
is a viable means of improving the puriﬁcation process and,
thus, potentially can contribute to a discovery being made.
Moreover, as the SCE and RC characters of NPs are closely
linked (Figure 2) − a correlation that opens multiple
possibilities for the interpretation of observed biological
activity/potency (Figure 3) − it can seldom be ruled out that
bioactivities originate, in full or in part, from the RC portion of
the NP (see scenarios C2 and D2 in Figure 3). The assessment
of purity and RC (see discussion above) and the establishment
of PARs
12 are potential valuable methods for the NPs discovery
process. In light of the ﬁndings of this study, all these factors
represent aspects that could stimulate future research design.
Challenging Spectroscopy in Structure Elucidation. It
is widely recognized that structure elucidation, unless supported
by direct atomic evidence from X−ray diﬀraction analysis, is
largely based on indirect spectroscopic evidence, primarily from
NMR, MS, IR, UV, and CD/ORD methods. As a result,
elucidation is an asymptotic process and can be compared with
a balancing act between the interpretation of the spectroscopic
data and the possible structural variations that can potentially
be aligned with it. Accordingly, the non-X-ray approach to
structure determination includes an element of uncertainly
(“residual doubt”), which depends on the depth of the analysis
in terms of the choice of type and number of spectroscopic
experiments, but also on how well the chemical space is probed
for alternative structures (e.g., isomers, compounds with
heteroatoms beyond N and O) that potentially ﬁtt h e
spectroscopic information.
There are clear indications in the literature that in-depth
studies lead to higher conﬁdence in the assigned structure
(reduced “residual doubt”) and frequently lead to reassignment
and revision of structures. One such example is the case of
hypurticin, a 2H-pyran-2-one, which was recently reassigned to
contain a 3′,5′,6′- rather than a 3′,4′,6′-tri-OAc side chain.
36
Mendoza-Espinosa et al. make a convincing case by employing
detailed density functional theory and 1H NMR analysis,
including 1H NMR spectral simulation and the synthesis of an
analogue. A similar approach in the authors’ laboratory also
employed 1H NMR spectral simulation and involved a detailed
analysis of the higher order J coupling patterns of the sugar
moiety. This led to the identiﬁcation of the ﬁrst cyanogenic
glycoside with β-allose rather than β-glucose attached to the
cyanogenic methine carbon, which has broad implications for
the enzymology of cyanogenesis.
37 During the present survey,
the authors frequently encountered articles in which the
reported 1H NMR spectroscopic data, in particular the
interpretation of coupling patterns and the deduction of
coupling constants (J), were lacking or ambiguous and, thus,
would not allow the distinction of diastereoisomers. In many
cases, even though other spectroscopic evidence was provided,
this did not provide the distinction of the given structure from
potential (stereo)isomeric alternatives. The most frequently
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the 1H NMR domain require a relatively tedious analysis of
their 1H NMR “multiplets between 3.2 and 4.5 ppm” to sort
out the correct J couplings and chemical shifts. The
aforementioned cases of hypurticin
36 and β-D-allopyranosy-
loxy-2-phenylacetonitrile,
37 among many others, demonstrate
that taking on the challenge of “residual doubt” can lead to
signiﬁcant discovery.
Challenging Preparative Chromatography. During the
writing of this review, the authors became aware of an excellent
book chapter by A. D. Wright, which includes a meta-analysis of
the literature regarding the isolation of marine NPs.
38 The
author analyzed 115 reports during 1995, published in Journal
of the American Chemical Society, Journal of Natural Products,
The Journal of Organic Chemistry, and Tetrahedron and recorded
parameters similar to the present survey. One aspect of the
study was the diﬀerentiation of stationary phases and speciﬁc
chromatographic methods. The analysis made indicated that
“average” isolation methods in marine NP chemistry might be
diﬀerent from those used for NPs from terrestrial organisms.
Distinct diﬀerences seem to exist with regard to the use of silica
gel (6% of studies analyzed in ref 38 compared with 57−71% in
the above discussion) or CCC (7% of studies analyzed in ref
38, 0.3−1.7% in the present survey, depending on time period).
While the surveys cannot be directly compared, future meta-
analyses of the NP literature, including the continuation of the
present AnaPurNa study, can likely beneﬁt from extended
parameter sets that enable addressing additional aspects in the
contemporary methods used to purify and analyze bioactive
NPs.
During the extensive literature study performed, the present
authors observed that only very few publications include new
preparative-scale analytical methods in their NP isolation
schemes. It seems that innovative chromatographic methods
would enhance the systematic exploitation of NP diversity. This
is exactly the chemical space that is the focus of the application
of metabolomics to the study of NPs. In eﬀect, metabolomics
absolutely requires an organized investigation of the thousands,
and possibility ten of thousands, of chemical entities that a
single organism may contain. A recent editorial in Phytochemical
Analysis points out that, although many articles include the
term “metabolomics” in their title, the content of the
publications concerned tend to reﬂect only standard method-
ology and reporting.
39
Integrity and Reproducibility. Ultimately, the depth (see
Methodology section) of the spectroscopic data of a quality-
controlled NP (Figure 1) and the thoroughness of their
reporting represent important parameters of the integrity in NP
research. This applies from two angles: from the perspective of
a novel structure and its discoverer(s), as mentioned above, it
eﬀects an ambiguity to the structure elucidation and the
amount of “residual doubt”. Recently, the term “NP integrity”
has been coined by the National Center for Complementary
and Alternative Medicine of the U.S. National Institutes of
Health in relation to research on biologically active agents used
in complementary and alternative medicine, particularly
including botanicals and other dietary supplements.
40 These
guidelines are intended to ensure reproducibility of preclinical,
translational, and clinical studies with NP agents, which are
known to exhibit much larger variation in constitution than
other common intervention materials, such as SCE-based
drugs. From the perspective of reproducibility, research
involving (re)isolation, characterization, and/or other oper-
ations with previously published NPs performed by the same or
other scientists, the integrity of spectroscopic information
inﬂuences the degree of certainty with which structures can be
dereplicated and/or distinguished from close congeners.
41 This
makes the depth of spectroscopic information, as assessed in
this survey, an element of NP integrity and a factor in
reproducibility.
Purity is another factor of integrity. Increasing considerations
of purity as a standard or required physicochemical parameter
might be (mis)interpreted as a quest for ever-increasing
purities. High purity certainly has its merit, because it allows
the NP to approach SCE status and simpliﬁes interpretation
and understanding of a biological outcome (Figures 2 and 3).
At the same time, requiring NPs to be highly pure often
imposes overly proportional or even unrealistic eﬀorts and costs
on the research. Depending on the biological application and
research aim, a certain degree of RC can also be of value, as
residually complex NPs more closely reﬂect the natural
character of a NP. Provided that RC and purity of a NP are
known and documented, even less pure materials can be
potentially useful and/or are suitable as unique research tools
for biological studies, as long as their greater chemical
complexity is considered during the interpretation of the
results (Figure 3). Examples of relevant biological topics that
can beneﬁt from the availability of such materials include
additive, synergistic, and antagonistic action and their use as
markers in standardization of biological agents such as
botanicals.
While even very thorough analysis may not solve the
challenge of reproducing identical NPs with identical RC
patterns, biological studies with such highly characterized NPs
(cNPs) at least can be compared on a more rational basis. The
suitability of NP and cNP materials, e.g., attaining certain
potency levels or conﬁrmation of activity at a given target, can
usually be assessed only after their puriﬁcation. Accordingly,
studies aimed at the biological evaluation of NPs can greatly
beneﬁt from assessing the status of any NP sourced from the
pipeline from crude NP to SCE/cNP (Figure 1) and from
publically disseminating this information as equally valuable
along with the chemical and biological data.
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Franzblau, and G. Cordell, as well as the late Dr. N. R.
Farnsworth. Finally, the authors wish to thank the Research
Journal of Natural Products Review
dx.doi.org/10.1021/np300066q | J. Nat. Prod. 2012, 75, 1243−1255 1254Open Access Publishing (ROAAP) Fund of the University of
Illinois at Chicago for ﬁnancial support toward the open access
publishing fee for this article.
■ DEDICATION
Dedicated to Dr. David C. Lankin, University of Illinois at
Chicago (UIC), on the occasion of his 70th birthday and in
recognition of his commitment and most valuable contributions
to pharmacognosy research and education at UIC, as well as his
collaborative spirit.
■ REFERENCES
(1) Cragg, G. M.; Grothaus, P. G.; Newman, D. J. Chem. Rev. 2009,
109, 3012−3043.
(2) Newman, D. J.; Cragg, G. M. J. Nat. Prod. 2007, 70, 461−477.
(3) Newman, D. J.; Cragg, G. M.; Snader, K. M. J. Nat. Prod. 2003,
66, 1022−1037.
(4) Cragg, G. M.; Newman, D. J.; Snader, K. M. J. Nat. Prod. 1997,
60,5 2 −60.
(5) Newman, D. J.; Cragg, G. M. J. Nat. Prod. 2012, 75, 311−335.
(6) Wagenaar, M. M. Molecules 2008, 13, 1406−1426.
(7) Nishtar, S. Lancet 2012, 379, 1084−1085.
(8) Chen, S.-N.; Lankin, D.; Chadwick, L. R.; Jaki, B. U.; Pauli, G. F.
Planta Med. 2009, 75, 757−762.
(9) Cordell, G. A.; Quinn-Beattie, M. L.; Farnsworth, N. R. Phytother.
Res. 2001, 15, 183−205.
(10) Henke, H. Preparative Gel Chromatography on Sephadex LH-20;
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